ImmuCell Corporation
ICCC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | – | $502 | $1,447 | $515 |
| Dep. & Amort. | – | $668 | $676 | $685 |
| Deferred Tax | – | $0 | $0 | $0 |
| Stock-Based Comp. | – | $67 | $52 | $69 |
| Change in WC | – | $400 | -$579 | -$1,235 |
| Other Non-Cash | – | -$35 | -$22 | -$37 |
| Operating Cash Flow | – | $1,601 | $1,574 | -$3 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | – | -$155 | -$329 | -$196 |
| Net Acquisitions | – | $29 | $0 | $0 |
| Inv. Purchases | – | $0 | $0 | $0 |
| Inv. Sales/Matur. | – | $0 | $0 | $0 |
| Other Inv. Act. | – | $0 | $0 | $0 |
| Investing Cash Flow | – | -$126 | -$329 | -$196 |
| Financing Activities | – | – | – | – |
| Debt Repay. | – | -$381 | -$380 | -$374 |
| Stock Issued | – | $330 | $19 | $815 |
| Stock Repurch. | – | $0 | $0 | $0 |
| Dividends Paid | – | $0 | $0 | $0 |
| Other Fin. Act. | – | -$25 | -$43 | -$292 |
| Financing Cash Flow | – | -$76 | -$404 | $149 |
| Forex Effect | – | $0 | $0 | $0 |
| Net Chg. in Cash | – | $1,399 | $841 | -$50 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | – | $4,599 | $3,758 | $3,809 |
| End Cash | – | $5,998 | $4,599 | $3,758 |
| Free Cash Flow | – | $1,446 | $1,245 | -$199 |